We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
EANM position paper: theranostics in brain tumours—the present and the future.
- Authors
Tolboom, Nelleke; Verger, Antoine; Albert, Nathalie L.; Brendel, Matthias; Cecchin, Diego; Fernandez, Pablo Aguiar; Fraioli, Francesco; Guedj, Eric; Herrmann, Ken; Traub-Weidinger, Tatjana; Morbelli, Silvia; Yakushev, Igor; Zucchetta, Pietro; Barthel, Henryk; Van Weehaeghe, Donatienne
- Abstract
The European Journal of Nuclear Medicine & Molecular Imaging has published a position paper on the use of theranostics in brain tumors. Theranostics, which involves using diagnostic imaging to identify specific molecular targets and then delivering targeted therapy, has shown promise in thyroid diseases, neuroendocrine tumors, and prostate cancer. The paper discusses the potential of theranostics in treating brain tumors, including meningiomas, gliomas, brain metastases, and pediatric brain tumors. It highlights the challenges in delivering therapeutics to the brain due to the blood-brain barrier and calls for further research and clinical trials to evaluate the efficacy of theranostic approaches in neuro-oncology.
- Subjects
BRAIN tumors; COMPANION diagnostics; NEUROENDOCRINE tumors; BLOOD-brain barrier; DRUG target; THYROID diseases
- Publication
European Journal of Nuclear Medicine & Molecular Imaging, 2023, Vol 51, Issue 1, p202
- ISSN
1619-7070
- Publication type
Article
- DOI
10.1007/s00259-023-06425-8